OXB has the technical and regulatory expertise to help you deliver the life-changing medicines of tomorrow.
Our commitment to medical innovation, proven experience of scaling up complex manufacturing processes and thorough understanding of product commercialisation give you everything you need to get your product to market.
State-of-the-art facilities
Oxford, UK
Viral vector manufacturing in UK
Benefit from:
- 6 GMP manufacturing suites
- 200L and 1,000L bioreactors
- 2 fill finish suites
- 17,030m2 (183,300ft2) total size of facilities
Greater Boston, US
Viral vector manufacturing in US
Benefit from:
- 4 GMP manufacturing suites
- 500L, 1,000L, and 2,000L bioreactors
- 1 fill finish suite
- 8,920m 2 (96,000ft2) size of facility
Lyon, France
Viral vector manufacturing in France
Benefit from:
- 3 GMP manufacturing suites
- 200L bioreactors
- 1 fill finish suite
- 6,500m2 (70,000ft2) size of facility
Strasbourg, France
Viral vector manufacturing in France
Benefit from:
- 2 GMP manufacturing suites
- 200L bioreactors
- 1 fill finish suite
- 4,900m2 (52,700ft2) size of facility
Benefit from our deep scientific understanding
Working with OXB gives you access to capabilities that go far beyond conventional contract manufacturing services for viral vectors. Our commercial experience, scientific understanding, and development expertise complement our state of the art manufacturing facilities. Our teams are passionate about helping you get the results you want.
Benefit from our rigorous controls
When you use an OXB platform, you get a comprehensive, end-to-end CMC service. You can be sure our quality-focused GMP manufacturing processes will support your viral vector product through every step of development through to commercialisation, all supported by robust and compliant analytics.
See our other services
Services overview
As a viral vector specialist with over 25 years’ experience in the cell and gene therapy industry, we have a thorough understanding of the challenges you face.
Analytics
We maintain our analytical assays within our in-house QC labs, allowing us to be confident in our ability to validate our methods to support clinical and commercial supply.
Process development
Lean on our process development expertise to help you reduce the time and expense involved in getting your next life-changing therapy to trial stage.
